Mesothelioma Foundation Experts Can Answer Your Questions!

The Mesothelioma Applied Research Foundation's team of experts is available to answer your questions about mesothelioma, its symptoms and treatments as well as options available to you. This help is a free service. We are not a law firm. Read more about the Mesothelioma Applied Research Foundation.

TO GET HELP CALL: (877) End-Meso or (877) 363-6376 or fill out the form to the right to be contacted by us.

Facebook Twitter YouTube Google Plus

The Meso Foundation Board of Directors: Michael J. Becich, MD, PhD

Meet Michael J. Becich, MD, PhD, Director

Michael J. Becich, MD, PhD, Director

Michael J. Becich, MD, PhD, is Professor and Chairman of the Department of Biomedical Informatics at the University of Pittsburgh School of Medicine. He is jointly appointed in Pathology, Information Sciences/Telecommunications and Clinical/Translational Research. He is Associate Director of the University of Pittsburgh Cancer Institute as well as the Clinical and Translational Science Institute at the University of Pittsburgh School of Medicine.

Dr. Becich’s research interests are focused on the interface between clinical informatics and bioinformatics. His research is funded by the CDC/NIOSH, DOD/TATRC/USAMRMC, NCI, NCATS, NHLBI and NLM, and includes clinical phenotyping of patients for genome wide association studies/next generation sequencing, tissue banking informatics, clinical informatics and bioinformatics with a special emphasis on data sharing. He has a long track record of working with the military, particularly the Telemedicine and Advanced Technology Research Center (TATRC) and the United States Army Medical Research Material Command (USAMRMC).

He is the principal investigator of the National Mesothelioma Virtual Bank (NMVB, see and University of Pittsburgh is the central coordinating center. NMVB is currently in the seventh year of funding from the National Institute of Occupational Safety and Health (NIOSH) of the Center for Disease Control (CDC) and is a partnership with the Mesothelioma Applied Research Foundation, Mount Sinai School of Medicine, New York University and the University of Pennsylvania. Dr. Becich and his team have been national leaders in tissue banking, honest broker practices, HIPAA compliant de-identification of clinical data and the accompanying biomedical informatics to enable translational research utilizing biospecimens.

Back to Board of Directors